The American Heart Association (AHA) has issued guidance on managing genetic tests that unexpectedly reveal gene variants linked to inherited cardiovascular disease (CVD). The statement outlines steps to assess variant risks, communicate with patients, and recommend follow-up care for high-risk variants. The guidance focuses on monogenic CVD genes and emphasizes the importance of interpreting and translating genetic findings into clinical practice. Recommendations include relaying information to patients, obtaining family history, and periodic reevaluation of genetic variants to ensure accurate risk assessment and appropriate medical interventions.
To Another Language
from source content
www.medscape.com
Key Insights Distilled From
by Megan Brooks at www.medscape.com 03-28-2023
https://www.medscape.com/viewarticle/990203Deeper Inquiries